Strabismus
Introduction
Strabismus, commonly known as 'squint' or 'crossed eyes,' is a condition characterized by an abnormal alignment of the eyes. This misalignment prevents both eyes from simultaneously focusing on a single point, leading to a loss of binocular vision. [1]
Concomitant strabismus, where the angle of deviation remains constant across all gaze positions, frequently manifests in early childhood and is considered a neurodevelopmental disorder of the visual system. It can present as convergent (esotropia), divergent (exotropia), or, less commonly, vertical misalignment. Strabismus is often associated with amblyopia, a reduction in visual acuity in one or both eyes that is not immediately correctable with corrective lenses and lacks underlying ocular pathology. This can occur either as a direct consequence of the eye deviation or when an underlying difference in vision between the eyes (such as anisometropia or unilateral cataract) leads to the squint. [1]
Several prenatal and early life environmental factors, including prematurity, maternal smoking, and maternal ill-health during pregnancy, as well as a high hyperopic refractive error in early childhood, are known to increase the risk of developing strabismus. [1]
Biological Basis
The biological basis of strabismus is complex, involving both genetic and environmental factors. Studies have shown a complex inheritance pattern, with some rare, monogenic subtypes linked to specific loci like 7p22.1 (STBMS1). It is also a feature of several rare syndromes, often accompanied by intellectual disability, such as Mietens–Weber syndrome and Lamb–Shaffer syndrome. [1]
Recent genome-wide association studies (GWAS) have identified common genetic polymorphisms that contribute to the risk of non-syndromic strabismus. One such study identified a locus within the first intron of WRB on chromosome 21, with rs2244352 being a key variant. More recently, research has highlighted a commonly occurring genetic variant within the NPLOC4–TSPAN10–PDE6G gene cluster on chromosome 17q25.3 as significantly associated with strabismus, with rs75078292 identified as the lead variant. This association is best described by a recessive model of inheritance. The genetic influence at this locus appears to be independent of refractive error and is minimally affected by amblyopia. [1]
Within this cluster, candidate causal variants include rs6420484, which causes a C177Y amino acid substitution in the TSPAN10 gene, and rs397693108, a 4-bp deletion predicted to cause a frameshift in TSPAN10. These variants have been linked to reduced TSPAN10 gene expression in brain tissues, and eQTL effects have also been observed for the adjacent genes PDE6G and ARL16. Functional studies suggest TSPAN10 is expressed in cone photoreceptors, NPLOC4 in ON-cone bipolar cells, and PDE6G in both rod and cone photoreceptors in the mouse retina. [1]
Clinical Relevance
Strabismus is a clinically relevant condition, frequently leading to childhood-onset visual impairment, often in one eye. Large-scale population studies, such as the UK Biobank, have reported a prevalence of self-reported strabismus around 2.0%. The identified genetic locus on 17q25.3, encompassing the NPLOC4–TSPAN10–PDE6G cluster, has a population-attributable risk of approximately 8.4%, indicating its significant role in conferring susceptibility. The association of this locus with strabismus has been independently replicated in cohorts of clinician-diagnosed children. [1]
Social Importance
Beyond its direct clinical implications, strabismus can have considerable social importance, affecting quality of life, educational attainment, and psychological well-being, particularly when it leads to persistent visual impairment or is visibly noticeable. Early diagnosis and intervention are crucial for improving visual outcomes and mitigating potential social challenges. Understanding the genetic underpinnings of strabismus, including common polymorphisms, opens new avenues for research into its causal mechanisms, potentially leading to improved diagnostic tools, targeted interventions, and preventive strategies. [1]
Phenotypic and Methodological Considerations
The primary limitation of this study stems from the reliance on self-reported strabismus in the UK Biobank cohort, which may introduce misclassification bias compared to clinician-diagnosed phenotypes. While the researchers validated the self-report by demonstrating a significant enrichment of comorbid traits like amblyopia, anisometropia, and asymmetric visual acuity among cases, and replicated the association in a clinician-diagnosed pediatric cohort, the broad definition of "squint or a turn in an eye since childhood" might encompass heterogeneous forms of strabismus. [1] This broad phenotyping could obscure genetic variants specific to particular strabismus subtypes, as evidenced by the lack of association with a variant previously linked to non-accommodative esotropia in another study. [1] Furthermore, the highly unbalanced case-control ratio (1345 cases vs. 65,349 controls) in the discovery sample, although addressed by using Firth bias-corrected logistic regression, can still pose statistical challenges and potentially influence effect size estimates. [1]
Generalizability and Genetic Architecture
The study's findings are predominantly based on a population of White British ancestry from the UK Biobank, which limits the generalizability of the identified genetic associations to other ethnic or ancestral groups. Although allele frequencies for the lead variant were presented across various ancestry groups, suggesting variability, the current fine-mapping efforts were unable to pinpoint the precise causal variant among approximately 20 highly linked variants, indicating that future studies in non-European populations might offer greater resolution for causal variant identification. [1] Moreover, while a significant locus was identified, strabismus is a complex trait with likely multiple genetic and environmental contributors. The discovery of a single locus, despite its strong association (OR ≈ 1.4–1.8), implies that a substantial portion of the genetic architecture and "missing heritability" for strabismus remains unexplained.
Unexplored Environmental Factors and Functional Mechanisms
Although the study adjusted for several covariates including age, gender, refractive error, and genetic principal components to mitigate confounding, the potential influence of other environmental or gene-environment interaction factors was not extensively explored. Socioeconomic position, measured by the Townsend Deprivation Index, showed only a modest difference between cases and controls, but other lifestyle or developmental exposures could play a significant role in strabismus etiology. [1] Furthermore, while the study provided strong evidence for the functional impact of the associated locus through eQTL analysis, demonstrating reduced expression of TSPAN10 in neural tissue and PDE6G in testis [1] these findings require further validation. The relevant tissues for strabismus development, such as extraocular muscle, retina, and visual cortex, were not included in the GTEx consortium data used for gene expression analysis. [1] Therefore, future functional studies are crucial to elucidate the precise mechanisms by which genes at this locus influence the visual system's response to visual experience during childhood, representing a key remaining knowledge gap.
Variants
Genetic variations across several loci have been identified as contributors to the complex etiology of strabismus, a condition characterized by misaligned eyes. Among these, the NPLOC4 gene and its associated variant rs75078292 have shown a significant association with strabismus. The NPLOC4 gene encodes an NPL4 homolog, a ubiquitin recognition factor involved in ubiquitin-dependent protein catabolism and the organization of the endoplasmic reticulum and Golgi apparatus. [1] Research indicates that rs75078292 is a lead variant within a gene cluster strongly linked to strabismus, operating under a recessive inheritance model with an odds ratio suggesting a substantial increase in risk. [1] This variant, which is in perfect linkage disequilibrium with rs7405453, has also been associated with macular thickness and myopia, suggesting its influence on broader ocular development and function, independent of refractive error and amblyopia. [2] The protein NPLOC4 also co-localizes with G Protein subunit alpha O1 (G0alpha), a marker for ON bipolar cells in the retina, indicating a potential role in retinal processing crucial for visual input and eye movement control. [1]
Other variants in non-coding and pseudogene regions, such as MIR548A1HG: rs375475939 and AGGF1P8 - FRG2HP: rs34349606, may exert their influence on strabismus by modulating gene expression. MIR548A1HG is a long non-coding RNA that hosts microRNA-548a-1, and variations within such regions can affect the production or activity of these regulatory RNAs, thereby impacting the expression of genes critical for ocular development or neurological pathways controlling eye alignment. Pseudogenes like AGGF1P8 and FRG2HP are typically non-functional copies of genes, but variants within them can sometimes influence the expression of their functional counterparts or act as regulatory elements, potentially affecting cellular processes vital for eye coordination. [1] Such regulatory changes could subtly alter the development of ocular muscles, nerves, or visual processing centers, contributing to the misalignment characteristic of strabismus.
Variants in genes involved in fundamental cellular and metabolic processes, like PHKB: rs116923583, ABCC11: rs17744237, and DNAH5: rs116105203, may also play a role in strabismus susceptibility. PHKB encodes a subunit of phosphorylase kinase, an enzyme crucial for glycogen metabolism and energy supply, particularly in muscles. Alterations in muscle energy or function due to PHKB variants could directly impact the extraocular muscles responsible for eye movement. ABCC11 codes for a transporter protein, and variants might affect cellular transport or detoxification, indirectly influencing the cellular environment in ocular tissues. [1] Furthermore, DNAH5 is vital for the proper function of cilia, and while primarily known for its role in ciliary dyskinesia, ciliary mechanisms are broadly involved in cellular signaling and development, suggesting that DNAH5 variants could impact developmental pathways essential for normal eye alignment. [1]
Finally, several variants are implicated in critical neuronal and developmental pathways. rs117636134, located near ADARB2 and LINC00200, could impact RNA editing processes mediated by ADARB2, which are crucial for nervous system development and function. Altered RNA editing might lead to dysfunctional proteins in neural circuits controlling eye movements. RGS3: rs72765667 is involved in regulating G-protein coupled receptor signaling, a fundamental process for neuronal communication and cell growth, with implications for the precise neural control required for coordinated eye movements. [1] Similarly, EXOC2: rs186974323 is part of the exocyst complex, essential for vesicle trafficking and synapse formation, processes critical for establishing and maintaining neural connections in the visual system. [1] Lastly, CSMD1: rs141951718 encodes a protein highly expressed in the brain, involved in complement regulation and synapse maturation. Variations in CSMD1 could disrupt synaptic plasticity and development, directly affecting the neural coordination necessary for binocular vision and preventing strabismus. [1]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs375475939 | MIR548A1HG | strabismus |
| rs116923583 | PHKB | strabismus |
| rs75078292 | NPLOC4 | strabismus |
| rs34349606 | AGGF1P8 - FRG2HP | strabismus |
| rs17744237 | ABCC11 | strabismus |
| rs117636134 | ADARB2, LINC00200 | strabismus |
| rs116105203 | DNAH5 | strabismus |
| rs72765677 | RGS3 - C14orf119P1 | strabismus |
| rs186974323 | EXOC2 - LINC01622 | strabismus |
| rs141951718 | CSMD1 | strabismus |
Definition and Core Terminology
Strabismus is precisely defined as an abnormal alignment of the eyes that results in a loss of binocular vision. This condition is commonly referred to by lay terms such as "squint" or "a turn in an eye". [1] A prevalent form, concomitant strabismus, is characterized by a constant angle of ocular deviation across all positions of gaze and often manifests early in childhood, being recognized as a neurodevelopmental disorder of the visual system. [1] The presence of strabismus is frequently associated with other ocular conditions, including amblyopia (often termed "lazy eye" due to poor vision not correctable by glasses), anisometropia (a significant difference in refractive error between the two eyes), and hypermetropia (long-sightedness). [1]
Classification and Subtypes
The classification of strabismus primarily distinguishes types based on the direction of ocular misalignment. Concomitant strabismus is most frequently categorized as either esotropia, where the eye turns inward (convergent), or exotropia, where the eye turns outward (divergent). [1] While horizontal deviations are most common, vertical misalignment can also occur as a primary deviation or in conjunction with esotropia or exotropia. [1] Within these classifications, clinicians differentiate between "manifest strabismus," which is consistently visible under normal viewing conditions with both eyes open, and "latent deviations" or phorias, which become apparent only when binocular vision is interrupted. [1] Furthermore, strabismus can be part of broader nosological systems, existing as a feature of several rare syndromes, often alongside intellectual disability, or as a rare, monogenic subtype. [1]
Diagnostic Criteria and Measurement Approaches
Diagnosis and measurement of strabismus typically involve specific clinical criteria and standardized approaches. Ocular misalignment is quantified using tests such as the simultaneous prism cover test and the alternate prism cover test, performed at both near (33 cm) and distance (6 m), with and without corrective lenses. [1] The magnitude of deviation is measured in prism diopters (pd), with large latent deviations operationally defined as greater than 10 pd for convergent deviations and greater than 15 pd for divergent deviations, to capture intermittent or decompensating cases. [1] In large-scale research studies, strabismus may be assessed through self-report, where participants indicate "a squint or a turn in an eye since childhood" as a reason for wearing glasses or contact lenses. [1] The validity of such self-reported phenotypes is often confirmed by analyzing the prevalence of associated conditions like amblyopia, anisometropia, and asymmetric visual acuity, and by replication in cohorts with clinician-diagnosed strabismus. [1]
Clinical Presentation and Associated Ocular Conditions
Strabismus, commonly referred to as a "squint" or "turn" in an eye, is characterized by ocular misalignment where the eyes do not point in the same direction. [1] This condition can present as concomitant strabismus, which is most often convergent (esotropia) or divergent (exotropia), although vertical misalignment may also occur either as a primary deviation or in conjunction with horizontal deviations. [1] Clinical phenotypes range from manifest strabismus, visible during normal binocular viewing, to large latent deviations (phorias), such as esophoria greater than 10 prism diopters (pd) or exophoria greater than 15 pd, which are more likely to capture intermittent or decompensating cases. [1] These presentations are frequently associated with childhood-onset visual impairment, typically in one eye.
A significant diagnostic correlation for strabismus is its frequent association with amblyopia, defined as poor visual acuity in one or both eyes not correctable by glasses and without other ocular pathology. [1] Individuals with self-reported strabismus demonstrate an 11.3-fold greater prevalence of self-reported amblyopia compared to controls. [1] Another common comorbidity is anisometropia, where the refractive power differs significantly between the two eyes; cases of strabismus show a 2.5-fold greater prevalence of anisometropia of 1.00 diopter (D) or more. [1] Furthermore, strabismus cases often present with a more hypermetropic refractive error (median +2.46 D versus +0.21 D in controls) and a notably earlier age of starting to wear glasses or contact lenses, typically ≤7 years. [1] The presence of these comorbidities, including asymmetric visual acuity (VA difference ≥ 0.2 logMAR), strongly supports the validity of self-reported strabismus phenotypes. [1]
Measurement and Diagnostic Approaches
The assessment of strabismus involves both subjective reports and objective clinical measurements to characterize the ocular misalignment. Self-reporting of strabismus, often gathered through questionnaires asking about a "squint or a turn in an eye since childhood" as a reason for wearing glasses, serves as an initial diagnostic indicator in large population studies. [1] To validate these self-reports, researchers analyze the co-occurrence of associated ocular traits like amblyopia, anisometropia, and asymmetric visual acuity, which are significantly over-represented in self-reported cases. [1] Clinically, ocular misalignment is precisely quantified using the simultaneous prism cover test and alternate prism cover test, performed at both near (33 cm) and distance (6 m), with and without corrective lenses if worn. [1]
These objective measurement approaches allow for the classification of strabismus as manifest (present in normal viewing) and the quantification of deviation in prism diopters (pd). [1] Horizontal deviations are categorized as esotropia (convergent) or exotropia (divergent), with specific thresholds (e.g., >10 pd for esophoria, >15 pd for exophoria) used to identify significant latent deviations. [1] Refractive error is measured using autorefraction, and conditions like anisometropia are quantified by the difference in spherical equivalent refractive error between the eyes. [1] Visual acuity is assessed and compared between eyes, with a difference of ≥0.2 logMAR indicating significant asymmetry. [1] Such comprehensive measurements are crucial for accurate diagnosis, phenotype characterization, and for distinguishing true strabismus cases from controls, as demonstrated by the replication of genetic associations in clinician-diagnosed cohorts of children. [1]
Variability and Phenotypic Diversity
Strabismus exhibits considerable variability and heterogeneity in its presentation, influenced by factors such as age, refractive status, and the specific type of deviation. While concomitant strabismus is broadly categorized into esotropia and exotropia, the exact age-of-onset and specific type are not always ascertained in all assessment methods, leading to a broad "self-reported strabismus" phenotype that encompasses various subtypes. [1] For instance, the association of genetic variants with strabismus can differ based on refractive status, showing a strong association in hyperopic individuals (OR=1.64) and evident association in emmetropes (OR=1.88), but a weaker association in myopic individuals (OR=1.11). [1] This suggests that the genetic underpinnings and clinical manifestations of strabismus can vary significantly across different refractive profiles.
Furthermore, the clinical presentation can show inter-individual variation, with some cases predominantly presenting as esotropia and others as exotropia, although the latter may sometimes be a consequence of previous surgical correction for esotropia. [1] The early age of onset for requiring glasses (median 5 years in cases vs. older in controls) and the frequently associated childhood-onset visual impairment highlight age-related patterns in its diagnostic significance. [1] While horizontal deviations are most common, vertical misalignment can occur, either primarily or in combination with horizontal deviations, adding to the phenotypic diversity. [1] Understanding this variability is critical for accurate diagnosis and for tailoring treatment strategies.
Genetic Predisposition
Strabismus is recognized as a complex trait with a significant genetic component, where both common and rarer inherited variants contribute to an individual's susceptibility. A notable discovery includes a commonly occurring genetic variant, rs75078292, located within the NPLOC4-TSPAN10-PDE6G gene cluster on chromosome 17q25.3. [1] This variant has a population-attributable risk of approximately 8.4%, indicating its substantial role in conferring susceptibility to strabismus. [1] The inheritance pattern for this specific locus is best described by a recessive model, where individuals homozygous for the minor allele face a significantly increased risk of developing the condition. [1]
Further investigation into this gene cluster identified strong candidate causal variants, including rs6420484, which causes a C177Y substitution in the TSPAN10 gene, and rs397693108, a 4-bp indel predicted to result in a frameshift in TSPAN10. [1] These variants are associated with reduced TSPAN10 gene expression in brain tissues, and similar eQTL effects were observed for the adjacent genes PDE6G and ARL16, suggesting that the risk of strabismus could be mediated through one or more of these genes, with TSPAN10 being the most likely causal eGene. [1] Beyond this specific locus, other studies have identified additional strabismus susceptibility loci, such as one on chromosome 7p, highlighting the polygenic nature of the condition where multiple genetic factors contribute to its development. [3]
Developmental and Environmental Influences
Strabismus often manifests in early childhood and is considered a neurodevelopmental disorder of the visual system, implying that early life processes are critical in its etiology. Several prenatal and early life environmental factors have been identified that increase the risk of developing strabismus. These include prematurity, exposure to maternal smoking during pregnancy, and maternal ill-health during the gestational period. [4] These early influences can disrupt the delicate processes of visual system development, leading to misalignment of the eyes.
Furthermore, a high hyperopic refractive error present in early childhood is another significant environmental risk factor for strabismus. [4] This uncorrected farsightedness can strain the visual system, potentially contributing to the development of eye misalignment. While socioeconomic factors, as measured by the Townsend Deprivation Index, show only a modest difference between individuals with and without strabismus, the combined impact of various developmental and environmental factors underscores the multifactorial nature of the condition. [1]
Interactions and Associated Ocular Conditions
The development of strabismus is not solely determined by isolated genetic or environmental factors but often arises from complex gene-environment interactions. The identified genetic locus, specifically the NPLOC4-TSPAN10-PDE6G cluster, is thought to influence the visual system's response to visual experience during childhood. [1] This suggests that genetic predispositions may modulate how an individual's visual system processes and adapts to environmental stimuli, potentially exacerbating or mitigating the risk of strabismus in the presence of specific early life exposures or visual challenges.
Strabismus is also frequently associated with other ocular conditions, which can either contribute to its onset or arise as a consequence. Amblyopia, characterized by poor visual acuity in one or both eyes, is a common comorbidity. [5] This reduced vision can either be a secondary effect of the squint itself, or pre-existing conditions like anisometropia (unequal refractive error between the eyes) or unilateral cataract can secondarily lead to the development of strabismus. [5] Although refractive error is a known comorbidity, the genetic association with rs75078292 was found to be independent of it, indicating that this specific genetic risk factor contributes to strabismus through mechanisms beyond simply influencing refractive status. [1] However, high hyperopia significantly increases the prevalence of strabismus, highlighting the complex interplay between refractive status and eye alignment. [1]
Biological Background of Strabismus
Strabismus, commonly known as a squint or "turn in the eye," is an abnormal alignment of the eyes that disrupts binocular vision, the ability to use both eyes together to perceive a single, three-dimensional image. This condition often manifests in early childhood and is considered a neurodevelopmental disorder of the visual system. [1] Strabismus can present as convergent (esotropia), where one eye turns inward, or divergent (exotropia), where one eye turns outward, though vertical misalignments can also occur. [1] It is frequently associated with amblyopia, a condition characterized by reduced visual acuity in one or both eyes that cannot be corrected with glasses, often developing as a consequence of the misalignment or due to underlying visual impairments like anisometropia or cataracts. [1] Environmental factors such as prematurity, maternal health during pregnancy, and high hyperopic refractive error in early childhood are known to increase the risk of strabismus. [6]
Genetic Predisposition and Identified Loci
The inheritance pattern of strabismus is complex, involving both genetic and environmental influences. While some rare, monogenic forms of strabismus exist, linked to specific loci like 7p22.1 (STBMS1), commonly occurring genetic variations in the general population also contribute significantly to susceptibility. [3] Genome-wide association studies (GWAS) have identified several loci associated with non-syndromic strabismus, including a region within the first intron of the WRB (tryptophan-rich basic protein) gene on chromosome 21. [1] A notable discovery is a common genetic variant within the NPLOC4-TSPAN10-PDE6G gene cluster on chromosome 17q25.3, which has been strongly associated with strabismus risk. [1]
Specifically, a lead variant, rs75078292, and other variants in high linkage disequilibrium within this cluster, show a significant association with strabismus, with a recessive inheritance model providing the best fit. [1] Among the candidate functional variants are a non-synonymous single nucleotide polymorphism (SNP), rs6420484, which causes a C177Y amino acid substitution in the TSPAN10 gene, and a 4-base pair indel, rs397693108, predicted to cause a frameshift in TSPAN10. [1] These genetic alterations are thought to mediate strabismus risk, potentially by influencing gene expression and subsequent protein function in critical visual system tissues. [1]
Gene Expression Regulation and Molecular Pathways
The genetic variants within the NPLOC4-TSPAN10-PDE6G cluster exert their influence by acting as expression quantitative trait loci (eQTLs), affecting the expression levels of nearby genes. The strabismus-associated risk allele, for instance, has been linked to reduced expression of TSPAN10 in brain tissues, including the cerebellum and human cerebellar hemisphere. [1] This reduction in TSPAN10 expression is consistent with mechanisms such as nonsense-mediated decay (NMD) of aberrant mRNA isoforms, suggesting a direct impact on the quantity of functional TSPAN10 protein available. [1]
Beyond TSPAN10, the risk allele also exhibits eQTL effects on other genes in the cluster, influencing reduced PDE6G expression in the testis and ARL16 mRNA levels in the thyroid. [1] While the precise relevance of these tissue-specific effects to strabismus development requires further study, TSPAN10 is currently considered the most likely causal eGene within this cluster due to its strong association with brain tissue expression. [1] The altered expression of these genes points to potential disruptions in signaling pathways and cellular functions critical for proper visual system development and function.
Cellular Functions and Retinal Biology of Associated Genes
The proteins encoded by the genes within the associated cluster play diverse roles, particularly within ocular tissues. TSPAN10 (Tetraspanin-10) is a membrane protein expressed in the retina, specifically co-localizing with cone photoreceptor inner and outer segments. [1] Although its specific functions in neuronal tissues like cranial nerves, retina, and brain are not fully understood, tetraspanins are generally involved in cell adhesion, migration, and differentiation, suggesting a role in the structural integrity or signaling within retinal cells. [1] The C177Y substitution in TSPAN10 is predicted to have functional consequences, potentially altering protein structure or interaction despite not affecting the conserved extracellular loop cysteines. [1]
NPLOC4 (NPL4 homolog, ubiquitin recognition factor) is expressed in ON-cone bipolar cells in the mouse retina, co-localizing with G0alpha, a marker for their dendritic tips. [1] Its predicted functions include metal ion binding, protein binding, and ubiquitin binding, indicating a potential role in ubiquitin-dependent protein catabolism or the organization of the endoplasmic reticulum and Golgi apparatus. [1] PDE6G (phosphodiesterase 6G) encodes the inhibitory γ-subunit of cGMP-phosphodiesterase, a key enzyme in rod phototransduction, and is expressed in both rod and cone photoreceptors. [1] Beyond its role in light perception, PDE6G also regulates MAPK (mitogen-activated protein kinase) signaling via GRK2, highlighting its involvement in broader cellular communication pathways. [1] Mutations in PDE6G are known to cause rare forms of retinitis pigmentosa, underscoring its importance in retinal health. [1]
Pathophysiological Implications for Visual System Development
The molecular and cellular disruptions stemming from variants in the NPLOC4-TSPAN10-PDE6G cluster likely contribute to the pathophysiological processes underlying strabismus. Given that strabismus is a neurodevelopmental disorder, altered gene expression and protein function in retinal photoreceptors, bipolar cells, or other neuronal tissues could impair the precise development and coordination of the visual system. [1] For instance, the role of TSPAN10 in cone photoreceptors and NPLOC4 in ON-cone bipolar cells suggests that defects could impact the processing of visual information at the earliest stages of the visual pathway. [1]
Furthermore, the involvement of PDE6G in phototransduction and MAPK signaling pathways indicates that its dysregulation could lead to broader retinal dysfunction, potentially affecting neuronal survival, synaptic plasticity, or the intricate communication network necessary for binocular vision. [1] Importantly, the association of the NPLOC4-TSPAN10-PDE6G locus with strabismus appears independent of common comorbidities like refractive error and amblyopia, suggesting a distinct and direct contribution to the disease mechanism. [1] This highlights the complex interplay of genetic factors affecting ocular development and function, leading to the observed misalignment of the eyes.
Genetic Regulation and Gene Expression Dysregulation
Strabismus susceptibility is significantly influenced by a common genetic variant located within the NPLOC4-TSPAN10-PDE6G gene cluster on chromosome 17q25.3. Specifically, the lead variant rs75078292, along with other highly linked variants, has been strongly associated with the condition. [1] Two prominent candidate causal variants identified are rs6420484, which results in a C177Y amino acid substitution in the TSPAN10 gene, and rs397693108, a 4-bp deletion predicted to cause a frameshift in TSPAN10. [1] These genetic alterations are linked to a reduction in TSPAN10 gene expression, particularly in brain tissues, indicating a critical gene regulation pathway where altered transcription or mRNA stability contributes to disease risk. [1]
While TSPAN10 is considered the most probable causal eGene, the risk allele also exhibits cis-eQTL effects on the expression of adjacent genes, PDE6G and ARL16, in certain tissues. [1] This suggests a complex regulatory landscape where a single genetic locus can broadly impact the expression of multiple genes, potentially through shared regulatory elements or chromatin organization. The resulting dysregulation of gene expression, especially the reduced levels of TSPAN10, likely perturbs downstream molecular pathways essential for normal visual system development, positioning altered gene regulation as a core disease-relevant mechanism in strabismus. [1]
Cellular Signaling and Retinal Function
The PDE6G gene, part of the associated cluster, encodes the inhibitory γ-subunit of cGMP-phosphodiesterase, a key enzyme in phototransduction pathways. [1] Beyond its well-established role in rod photoreceptor signaling, PDE6G is also known to regulate the MAPK (mitogen-activated protein kinase) signaling pathway through its interaction with GRK2 (G protein-coupled receptor kinase 2). [1] This highlights a crucial signaling cascade where PDE6G influences cellular responses beyond light detection, potentially affecting neuronal development or plasticity in the visual system. Perturbations in cGMP metabolism or MAPK signaling due to dysregulated PDE6G expression could disrupt the delicate balance required for eye alignment and binocular vision.
TSPAN10, a tetraspanin, is expressed in neuronal tissues, including the retina, cranial nerves, and brain, and co-localizes with cone photoreceptor markers in the mouse retina. [1] Tetraspanins are known to organize protein complexes on cell membranes, influencing cell adhesion, migration, and signaling, though the specific roles of TSPAN10 in these processes within neuronal tissues are still being investigated. [1] The C177Y substitution in TSPAN10 caused by rs6420484 affects a cysteine residue, which could potentially alter protein structure or interactions, thereby impacting its function in cellular signaling or membrane organization. [1]
Protein Modification and Metabolic Regulation
The NPLOC4 gene, also within the implicated cluster, encodes NPL4 homolog, a ubiquitin recognition factor. [1] Its predicted functions include metal ion binding, protein binding, and ubiquitin binding, suggesting a significant role in ubiquitin-dependent catabolism, a crucial metabolic pathway for protein turnover and cellular waste management. [1] Additionally, NPLOC4 is thought to be involved in endoplasmic reticulum (ER) and Golgi organization, which are vital for protein synthesis, modification, and trafficking. [1] Dysregulation of NPLOC4 could therefore impair cellular quality control mechanisms, leading to the accumulation of misfolded proteins or disruptions in the biosynthesis and transport of essential visual system components.
The involvement of NPLOC4 in ubiquitination pathways points to a broader regulatory mechanism where precise control over protein stability and degradation is essential for neuronal health and function. [1] Alterations in these processes could compromise the structural integrity or functional efficiency of retinal neurons and their connections, contributing to the neurodevelopmental aspects of strabismus. Furthermore, PDE6G's role in cGMP metabolism represents a flux control point in energy and signal transduction within photoreceptors, where its dysregulation could impact the energy balance and responsiveness of these critical visual cells. [1]
Systems-Level Integration in Visual Neurodevelopment
Strabismus is recognized as a neurodevelopmental disorder of the visual system, implying that its underlying mechanisms involve complex interactions across multiple cell types and pathways. [1] The genes in the associated cluster exhibit specific expression patterns within the retina, indicating their roles in distinct neuronal populations. TSPAN10 is localized to cone photoreceptors, while NPLOC4 is found in ON bipolar interneurons, specifically co-localizing with G0alpha at their dendritic tips. [1] PDE6G is expressed in both rod and cone photoreceptors. [7]
This intricate cellular localization highlights a network of interactions where the proper function of each gene is critical for the integrated processing of visual information. [1] Dysregulation of any of these genes, as suggested by the identified genetic variants, could lead to pathway crosstalk disruptions or impaired network interactions within the retina and broader visual pathways. Such disruptions could manifest as emergent properties affecting eye alignment and binocular vision, independent of refractive error and only minimally attenuated by amblyopia, underscoring the primary neurodevelopmental impact of these genetic pathways on strabismus. [1]
Genetic Predisposition and Risk Stratification
Genetic factors play a significant role in the susceptibility to strabismus, a neurodevelopmental disorder of the visual system often manifesting in early childhood. [1] A commonly occurring genetic variant, rs75078292, located within the NPLOC4-TSPAN10-PDE6G gene cluster, is strongly associated with an increased risk of strabismus. [1] This association is particularly pronounced under a recessive inheritance model, where individuals homozygous for the minor allele exhibit a substantially higher odds ratio for developing the condition (approximately 1.4–1.8). [1] The population-attributable risk for this locus is estimated at 8.4%, underscoring its significant contribution to overall strabismus prevalence. [1]
This genetic insight offers a valuable tool for risk stratification, enabling the identification of individuals at elevated genetic risk for strabismus. Further refinement of risk assessment can be achieved by considering refractive error status, as the genetic association is notably strong in hyperopic individuals (OR=1.64) and also present in emmetropes (OR=1.88), but not evident in myopic individuals. [1] Such personalized risk profiles, especially when combined with clinical indicators like early-onset hyperopia, could facilitate targeted screening programs and earlier interventions to prevent or mitigate the long-term visual impairments associated with strabismus. [1]
Clinical Diagnosis and Associated Ocular Conditions
Strabismus is frequently linked with several co-occurring ocular conditions, which are critical for its comprehensive diagnosis and management. Individuals with strabismus exhibit a significantly higher prevalence of amblyopia, experiencing an 11.3-fold greater rate of this "lazy eye" condition compared to controls. [1] Similarly, anisometropia, defined as a notable difference in refractive power between the two eyes, is 2.5 times more prevalent in strabismus cases. [1] These comorbidities, along with asymmetric visual acuity, are strongly over-represented in individuals with strabismus, validating the clinical utility of these indicators in diagnosis and monitoring. [1]
Furthermore, strabismus cases are characterized by a more hypermetropic refractive error (median +2.46 D versus +0.21 D in controls) and an earlier age of starting to wear corrective lenses (median 5 years versus 10 years). [1] High hyperopic refractive error in early childhood is a well-established risk factor for strabismus, and its strong presence in affected individuals highlights the importance of early ophthalmic examinations. [1] Recognizing these interconnected ocular traits is crucial for accurate diagnosis, assessing the severity of visual pathway involvement, and guiding therapeutic strategies aimed at preserving binocular vision and preventing secondary complications.
Molecular Mechanisms and Broader Ocular Health Implications
The identification of genetic variants within the NPLOC4-TSPAN10-PDE6G gene cluster associated with strabismus provides valuable insights into potential underlying molecular mechanisms. [1] Immunolocalization studies in mouse retina reveal that NPLOC4 co-localizes with G0alpha, a marker for the dendritic tips of ON bipolar interneurons, while TSPAN10 co-localizes with Peanut Agglutinin Lectin (PNA), a marker for cone photoreceptor inner and outer segments. [1] These findings suggest that the genes in this cluster may play roles in retinal neuronal function and photoreceptor integrity, potentially influencing the complex neurodevelopmental processes that govern eye alignment and visual processing.
Beyond strabismus, variants in this genetic locus have been implicated in a broader spectrum of ocular conditions, indicating pleiotropic effects. For instance, a variant in perfect linkage disequilibrium with the lead strabismus variant is associated with macular thickness, and other SNPs within NPLOC4 are linked to age-related macular degeneration (AMD) and eye color. [1] A TSPAN10 variant is also associated with microvascular diameter in the human retina. [1] While the association with strabismus was largely independent of these broader ocular pathologies, these findings collectively suggest that the NPLOC4-TSPAN10-PDE6G cluster is critical for diverse aspects of ocular development and health, opening avenues for research into shared genetic pathways and potential therapeutic targets.
Frequently Asked Questions About Strabismus
These questions address the most important and specific aspects of strabismus based on current genetic research.
1. If my parents had crossed eyes, will my kids inherit it?
Yes, there's a genetic component to strabismus. While it's complex, research shows a familial link, meaning it can run in families. Specific genetic variants, like those in the NPLOC4–TSPAN10–PDE6G gene cluster, can significantly increase the risk, sometimes following a recessive inheritance pattern. So, if your parents had it, your children might have a higher chance, but it's not a certainty.
2. Did my pregnancy habits cause my child's strabismus?
It's complex, but some early life factors are known to increase risk. For instance, prematurity, maternal smoking, and certain maternal illnesses during pregnancy have been linked to a higher chance of a child developing strabismus. These are environmental factors that can interact with a child's genetic predisposition.
3. My sibling has a squint, but I don't; why the difference?
Even within families, genetic expression and environmental exposures can vary. While common genetic variants, like those in the NPLOC4–TSPAN10–PDE6G cluster, contribute to risk, not everyone with the variants will develop strabismus. Other genes, environmental factors, or even chance can play a role in why one sibling is affected and another isn't.
4. Beyond looks, how does my strabismus affect daily life?
Strabismus can significantly impact your daily life beyond appearance. It often leads to reduced vision, especially in one eye, and can affect your binocular vision (how your eyes work together). This can influence educational attainment, psychological well-being, and overall quality of life if not addressed early.
5. Can I prevent my child from developing a squint?
While you can't change your child's genetic predisposition, addressing known environmental risk factors can help. Avoiding maternal smoking during pregnancy and ensuring good maternal health are important. Early detection and correction of high refractive errors in childhood can also mitigate the risk or severity.
6. Should I get a DNA test to understand my strabismus?
Genetic testing is becoming more informative for strabismus. It can identify specific genetic variants, such as those in the NPLOC4–TSPAN10–PDE6G cluster, that significantly contribute to the risk. Understanding your genetic profile could potentially aid in future research, personalized interventions, or family planning discussions, but it's not typically a standard diagnostic tool yet.
7. I'm not White British; does my background change my squint risk?
Yes, genetic risk factors can vary across different ancestral groups. The identified genetic associations for strabismus are predominantly based on studies of White British populations. While the lead variant's allele frequencies differ across groups, further research in non-European populations is needed to fully understand ancestry-specific risks and pinpoint causal variants.
8. Are my genes or my environment more responsible for my squint?
Strabismus is a complex condition influenced by both genes and environment. While common genetic variants, like the one on chromosome 17q25.3, have a significant population-attributable risk, environmental factors like prematurity or maternal health during pregnancy also play a role. It's often a combination of these factors that determines an individual's risk.
9. Are my lazy eye and squint always connected?
They are very often connected. Amblyopia, commonly known as "lazy eye," is a frequent consequence of strabismus. When the eyes are misaligned, the brain may suppress the image from the deviating eye, leading to reduced visual acuity in that eye. However, amblyopia can also occur due to other vision differences, like a large difference in prescription between the eyes.
10. Does having a strong prescription affect my squint?
Yes, a high hyperopic (farsighted) refractive error in early childhood is a known risk factor for developing strabismus, particularly convergent types (esotropia). This can be due to the eyes constantly trying to over-focus to see clearly, which can lead to an inward turn. Early correction of such refractive errors is important.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Plotnikov D, et al. "A commonly occurring genetic variant within the NPLOC4-TSPAN10-PDE6G gene cluster is associated with the risk of strabismus." Human Genetics, vol. 138, 2019, pp. 723–737.
[2] Gao, X. R., Huang, H., & Kim, H. "Genome-wide association analyses identify 139 loci associated with macular thickness in the UK Biobank cohort." Human Molecular Genetics, 2019.
[3] Parikh, V. et al. "A strabismus susceptibility locus on chromosome 7p." Proceedings of the National Academy of Sciences of the United States of America, 2003.
[4] Atkinson, J. et al. "Prevalence of and early-life influences on childhood strabismus: findings from the millennium cohort study." Archives of Pediatrics & Adolescent Medicine, 1996.
[5] Robaei, D. et al. "Prevalence and causes of amblyopia and strabismus in a population-based sample of 6-year-old children." Ophthalmology, 2010.
[6] Pathai, S., Cumberland, P. M., & Rahi, J. S. "Prevalence of and early-life influences on childhood strabismus: findings from the millennium cohort study." Archives of Pediatrics & Adolescent Medicine, 2010.
[7] Dvir, L., et al. "Autosomal-Recessive Early-Onset Retinitis Pigmentosa Caused by a Mutation in PDE6G, the Gene Encoding the Gamma Subunit of Rod cGMP Phosphodiesterase." Am J Hum Genet, vol. 87, no. 2, 2010, pp. 258–264.